Cited by 323Chronic Obstructive Pulmonary Disease (COPD) ResearchOral microbiology and periodontitis researchAsthma and respiratory diseases

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease

Open access

Huang, Yvonne J., Sethi, Sanjay, Murphy, Timothy, Nariya, Snehal, Boushey, Homer A., Lynch, Susan V.·2014·Journal of Clinical Microbiology

DOI 10.1128/jcm.00035-14PMC PMC4136157

Open this paper in CoChat — free account Open PDF

Abstract

Specific bacterial species are implicated in the pathogenesis of exacerbations of chronic obstructive pulmonary disease (COPD). However, recent studies of clinically stable COPD patients have demonstrated a greater diversity of airway microbiota, whose role in acute exacerbations is unclear. In this study, temporal changes in the airway microbiome before, at the onset of, and after an acute exacerbation were examined in 60 sputum samples collected from subjects enrolled in a longitudinal study of bacterial infection in COPD. Microbiome composition and predicted functions were examined using 16S rRNA-based culture-independent profiling methods. Shifts in the abundance (≥ 2-fold, P < 0.05) of many taxa at exacerbation and after treatment were observed. Microbiota members that were increased at exacerbation were primarily of the Proteobacteria phylum, including nontypical COPD pathogens. Changes in the bacterial composition after treatment for an exacerbation differed significantly among the therapy regimens clinically prescribed (antibiotics only, oral corticosteroids only, or both). Treatment with antibiotics alone primarily decreased the abundance of Proteobacteria, with the prolonged suppression of some microbiota members being observed. In contrast, treatment with corticosteroids alone led to enrichment for Proteobacteria and members of other phyla. Predicted metagenomes of particular microbiota members involved in these compositional shifts indicated exacerbation-associated loss of functions involved in the synthesis of antimicrobial and anti-inflammatory products, alongside enrichment in functions related to pathogen-elicited inflammation. These trends reversed upon clinical recovery. Further larger studies will be necessary to determine whether specific compositional or functional changes detected in the airway microbiome could be useful indicators of exacerbation development or outcome.

Integrity signals

Registry

Crossref · 10.1128/jcm.00035-14

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

vegan: Community Ecology Package
Oksanen, J., Simpson, G. L., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O’Hara, R. B., Sólymos, P., Stevens, M. H. H., Szöcs, E., et al. (2001) · doi:10.32614/cran.package.vegan · Cited by 27,099
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences
Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
PAUWELS, R. A., Buist, A. S., CALVERLEY, P. M. A., Jenkins, C. R., & Hurd, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,572
Picante: R tools for integrating phylogenies and ecology
Kembel, S. W., Cowan, P. D., Helmus, M. R., Cornwell, W. K., Morlon, H., Ackerly, D. D., Blomberg, S. P., & Webb, C. O. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq166 · Cited by 6,192
Conservation evaluation and phylogenetic diversity
Faith, D. (1992) · Biological Conservation · doi:10.1016/0006-3207(92)91201-3 · Cited by 5,495

Flagged first, then by citations

Show all 48 references

Sorted by citations

Items 101–200 of 322

The microbiome of the human lower airways: a next generation sequencing perspective
Aho, V. T. E., Pereira, P. A. B., Haahtela, T., Pawankar, R., Auvinen, P., & Koskinen, K. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0074-z · Cited by 47
Functional Metagenomics of the Bronchial Microbiome in COPD
Millares, L., Pérez‐Brocal, V., Ferrari, R. G., Gallego, M., Pomares, X., García-Núñez, M., Montón, C., Capilla, S., Monsó, E., & Moyá, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144448 · Cited by 48
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome
Pailhories, H., Herrmann, J., Velo‐Suárez, L., Lamoureux, C., Beauruelle, C., Burgel, P., & Héry-Arnaud, G. (2022) · European Respiratory Review · doi:10.1183/16000617.0259-2021 · Cited by 46
Exacerbation induces a microbiota shift in sputa of COPD patients
Jubinville, É., Veillette, M., Milot, J., Maltais, F., Comeau, A., Lévesque, R. C., & Duchaine, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194355 · Cited by 45
Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease
Kotlyarov, S. N., & Котлярова, А. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147634 · Cited by 50
Characterising the respiratory microbiome
Watson, R. L., de Koff, E. M., & Bogaert, D. (2018) · European Respiratory Journal · doi:10.1183/13993003.01711-2018 · Cited by 45
Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases
Chellappan, D. K., Ning, Q. L. S., Min, S. K. S., Bin, S. Y., Pang, J.-C., Shi, T. P., Mei, S. W. E., Yee, T. H., Qi, O. J., Thangavelu, L. P., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108732 · Cited by 44
The mechanism or mechanisms driving atopic asthma initiation: The infant respiratory microbiome moves to center stage
Holt, P. G. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.011 · Cited by 43
Lung and Gut Microbiome in COPD
Karakasidis, E., Kotsiou, O. S., & Gourgoulianis, K. I. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050804 · Cited by 46
Inhaled corticosteroids and the increased risk of pneumonia: what’s new? A 2015 updated review
Iannella, H. A., Luna, C. M., & WATERER, G. W. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465816630208 · Cited by 42
Oropharyngeal and Sputum Microbiomes Are Similar Following Exacerbation of Chronic Obstructive Pulmonary Disease
Liu, H., Zhang, S., Yang, W., Su, X.-F., He, Y., Zhou, H., & Su, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01163 · Cited by 40
Altered Airway Microbiota Composition in Patients With Pulmonary Hypertension
Zhang, C., Zhang, T., Lu, W., Duan, X., Luo, X., Liu, S., Chen, Y., Li, Y., Chen, J., Liao, J., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15025 · Cited by 42
The Effects of Corticosteroids on the Respiratory Microbiome: A Systematic Review
Hartmann, J. E., Albrich, W. C., Dmitrijeva, M., & Kahlert, C. R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.588584 · Cited by 42
Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections
Denny, J. E., Powell, W. L., & Schmidt, N. W. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00041 · Cited by 41
Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae
Euba, B., López-López, N., Rodríguez-Arce, I., Fernández-Calvet, A., Barberán, M., Caturla, N., Martí, S., Díez‐Martínez, R., & Garmendia, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-13034-7 · Cited by 40
The Human Respiratory Microbiome: Implications and Impact
Mitchell, A. B., & Glanville, A. R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1617441 · Cited by 38
Inhaled Corticosteroids and the Lung Microbiome in COPD
Keir, H. R., Contoli, M., & Chalmers, J. D. (2021) · Biomedicines · doi:10.3390/biomedicines9101312 · Cited by 42
Bacterial–viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospects
D’Anna, S. E., Balbi, B., Cappello, F., Carone, M., & Stefano, A. D. (2016) · International Journal of COPD · doi:10.2147/copd.s93398 · Cited by 38
Microbiome in chronic obstructive pulmonary disease
Monsó, E. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.20 · Cited by 39
Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease
de la Rosa, D., López-Campos, J. L., Navarrete, B. A., Rubio, M. C., Cantón, R., Rivero, J. L. G., Carro, L. M., Fuster, C. O., & Martínez‐García, M. Á. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2020.08.006 · Cited by 38
The fermentation product 2,3-butanediol alters P. aeruginosa clearance, cytokine response and the lung microbiome
Nguyen, M. T., Sharma, A., Wu, W., Gomi, R., Sung, B., Hospodsky, D., Angenent, L. T., & Worgall, S. (2016) · The ISME Journal · doi:10.1038/ismej.2016.76 · Cited by 36
Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of target genes
Ramsheh, M. Y., Haldar, K., Bafadhel, M., George, L., Free, R. C., John, C., Reeve, N. F., Ziegler‐Heitbrock, L., Gut, I. G., Singh, D., et al. (2019) · Thorax · doi:10.1136/thoraxjnl-2019-213485 · Cited by 36
Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
Tangedal, S., Nielsen, R., Aanerud, M., Persson, L. J. P., Wiker, H. G., Bakke, P. S., Hiemstra, P. S., & Eagan, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222449 · Cited by 35
Influence of the Lung Microbiota Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: The Controversial Use of Corticosteroid and Antibiotic Treatments and the Role of Eosinophils as a Disease Marker
Toraldo, D. M., & Conte, L. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3875 · Cited by 36
Bronchial Microbiome, PA Biofilm-Forming Capacity and Exacerbation in Severe COPD Patients Colonized by P. Aeruginosa
García-Núñez, M., Martí, S., Puig, C., Pérez‐Brocal, V., Millares, L., Santos, S., Ardanuy, C., Moyá, A., Liñares, J., & Monsó, E. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0127 · Cited by 37
Precision respiratory medicine and the microbiome
Rogers, G. B., & Wesselingh, S. L. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00476-2 · Cited by 35
Exacerbation of Chronic Obstructive Pulmonary Disease
Zhou, X., Li, Q., & Zhou, X. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-015-0605-9 · Cited by 34
Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics
Haldar, K., Bafadhel, M., Lau, K. E. M., Berg, A., Kwambana-Adams, B., Kebadze, T., Ramsheh, M. Y., Barker, B., Haldar, P., Johnston, S. L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182833 · Cited by 32
The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations
Huang, Y. J., & Boushey, H. A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201506-319aw · Cited by 31
Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa
Mahomed, T. G., Peters, R. P. H., Allam, M., Ismail, A., Mtshali, S., Mahomed, A. G., Ueckermann, V., Kock, M. M., & Ehlers, M. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-99127-w · Cited by 30
The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions
Millares, L., & Monsó, E. (2022) · International Journal of COPD · doi:10.2147/copd.s371958 · Cited by 32
The relevance of eosinophils in chronic obstructive pulmonary disease: inflammation, microbiome, and clinical outcomes
Higham, A., Beech, A. S., & Singh, D. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae153 · Cited by 30
Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment
Alsayed, A. R., Abed, A. I., Khader, H. A., Al-Shdifat, L., Hasoun, L., Al‐Rshaidat, M. M. D., Alkhatib, M., & Zihlif, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044086 · Cited by 32
The nasopharyngeal microbiome
Cleary, D. W., & Clarke, S. C. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170041 · Cited by 31
Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America
Schoonbroodt, S., Ichanté, J.-L., Boffé, S., Devos, N., Devaster, J., Taddei, L., Rondini, S., Arora, A. K., Pascal, T. G., & Malvaux, L. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1098133 · Cited by 28
Exhaled breath condensate to discriminate individuals with different smoking habits by GC–TOF/MS
Peralbo‐Molina, Á., Calderón-Santiago, M., Gámez, B. J., de Castro, M. D. L., & Priego‐Capote, F. (2017) · Scientific Reports · doi:10.1038/s41598-017-01564-z · Cited by 27
The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
Millares, L., Bermudo, G., Pérez‐Brocal, V., Domingo, C., García-Núñez, M., Pomares, X., Moyá, A., & Monsó, E. (2017) · BMC Microbiology · doi:10.1186/s12866-017-0933-6 · Cited by 27
Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease
Diao, W., Shen, N., Du, Y., Erb‐Downward, J. R., Sun, X., Guo, C., Qian, K., Huffnagle, G. B., Gyetko, M. R., & He, B. (2018) · International Journal of COPD · doi:10.2147/copd.s167618 · Cited by 25
Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD
Liu, H., Zheng, D., Lin, Y.-X., Liu, Z., Liang, Z., Su, J., Chen, R., Zhou, H., & Wang, Z. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105095 · Cited by 28
The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort
Wang, J., Chai, J., Sun, L., Zhao, J., & Chang, C. H. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05313-y · Cited by 27
Predicting BPD: Lessons Learned From the Airway Microbiome of Preterm Infants
Gentle, S. J., & Lal, C. V. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00564 · Cited by 26
MicroRNA Let-7 Induces M2 Macrophage Polarization in COPD Emphysema Through the IL-6/STAT3 Pathway
Liu, T., Zhang, Z., Shen, W., Wu, Y., & Bian, T. (2023) · International Journal of COPD · doi:10.2147/copd.s404850 · Cited by 26
A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiome
Shah, H., & Ng, T. L. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-595 · Cited by 24
Microbial and host immune factors as drivers of COPD
Mika, M., Nita, I., Morf, L., Qi, W., Beyeler, S., Bernasconi, E., Marsland, B. J., Ott, S. R., von Garnier, C., & Hilty, M. (2018) · ERJ Open Research · doi:10.1183/23120541.00015-2018 · Cited by 26
Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones?
Jacobs, D. M., Pandit, U., & Sethi, S. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000533 · Cited by 25
The respiratory microbiome of HIV-infected individuals
Lawani, M. B., & Morris, A. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1206469 · Cited by 26
Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract
Corsini, B., Díez‐Martínez, R., Aguinagalde, L., González‐Camacho, F., García‐Fernández, E., Letrado, P., Garcı́a, P., & Yuste, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02212-17 · Cited by 24
The pulmonary microbiome: challenges of a new paradigm
Costa, A. N., da Costa, F. M., Campos, S. V., Salles, R. K., & Athanazio, R. A. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562017000000209 · Cited by 29
The host microbiome and impact of tuberculosis chemotherapy
O’Toole, R., & Gautam, S. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.08.015 · Cited by 24
The airway microbiota and exacerbations of COPD
Leiten, E. O., Nielsen, R., Wiker, H. G., Bakke, P. S., Martinsen, E. M. H., Drengenes, C., Tangedal, S., Husebø, G. R., & Eagan, T. (2020) · ERJ Open Research · doi:10.1183/23120541.00168-2020 · Cited by 23
Potential Implications of the Lung Microbiota in Patients with Chronic Obstruction Pulmonary Disease and Non-Small Cell Lung Cancer
He, J., Chen, Q., Wu, S., Wang, D., Zhang, S.-Y., Zhang, S., Chen, R., Wang, J., Wang, Z., & Yu, C.-H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.937864 · Cited by 23
JTD special edition 'Hot Topics in COPD'-The microbiome in COPD.
Chambers, D. C., Gellatly, S. L., Hugenholtz, P., & Hansbro, P. M. (2014) · PubMed Central · doi:10.3978/j.issn.2072-1439.2014.11.08 · Cited by 22
Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths
Li, Q., Larivée, P., Courteau, J., Couillard, S., Poder, T. G., Carrier, N., Bélanger, M., & Vanasse, A. (2019) · International Journal of COPD · doi:10.2147/copd.s187375 · Cited by 22
Functional, transcriptional, and microbial shifts associated with healthy pulmonary aging in rhesus macaques
Rhoades, N. S., Davies, M., Lewis, S. A., Cinco, I. R., Kohama, S. G., Bermudez, L. E., Winthrop, K. L., Fuss, C., Mattison, J. A., Spindel, E. R., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110725 · Cited by 22
Applying Next-Generation Sequencing and Multi-Omics in Chronic Obstructive Pulmonary Disease
Tiew, P. Y., Meldrum, O. W., & Chotirmall, S. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032955 · Cited by 21
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation
Zinter, M. S., Dvorak, C. C., Mayday, M. Y., Reyes, G. A., Simon, M. R., Pearce, E. M., Kim, H., Shaw, P. J., Rowan, C. M., Auletta, J. J., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02999-4 · Cited by 21
Mini-review: from in vitro to ex vivo studies: an overview of alternative methods for the study of medical biofilms
Castelo‐Branco, D. D. S. C. M., Amando, B. R., Ocadaque, C. J., de Aguiar, L., Paiva, D. D. D. Q., Diógenes, E. M., Guedes, G. M. D. M., Costa, C. L., Santos-Filho, A. S. P., de Andrade, A. R. C., et al. (2020) · Biofouling · doi:10.1080/08927014.2020.1859499 · Cited by 22
Disruptions in oral and nasal microbiota in biomass and tobacco smoke associated chronic obstructive pulmonary disease
Agarwal, D. M., Dhotre, D. P., Kumbhare, S. V., Gaike, A. H., Brashier, B. B., Shouche, Y. S., Juvekar, S. K., & Salvi, S. (2021) · Archives of Microbiology · doi:10.1007/s00203-020-02155-9 · Cited by 22
Lung Microbiome in Human Health and Diseases
Chauhan, N. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00077-2 · Cited by 20
Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians
Luo, L., Tang, J., Du, X., & Li, N. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107586 · Cited by 21
The Role of Inflammation in the Pathogenesis of Comorbidity of Chronic Obstructive Pulmonary Disease and Pulmonary Tuberculosis
Kotlyarov, S. N., & Оськин, Д. Н. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062378 · Cited by 23
Airway microbiota is associated with the severity of non‐CF bronchiectasis
Li, L., Zhang, J., Li, Z., Zhang, C., Bi, J., Zhou, J., Song, Y., & Shao, C. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13279 · Cited by 18
Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations
Mao, X., Li, Y., Shi, P., Zhu, Z., Sun, J., Xue, Y., Wan, Z., Yang, D., Ma, T., Wang, J., et al. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106335 · Cited by 19
Macrophages and the microbiome in chronic obstructive pulmonary disease
Sandhu, K. K., Scott, A., Tatler, A. L., Belchamber, K. B. R., & Cox, M. J. (2024) · European Respiratory Review · doi:10.1183/16000617.0053-2024 · Cited by 23
The lung microbiome and transplantation
Mitchell, A. B. (2019) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000631 · Cited by 19
Bacteria Residing at Root Canals Can Induce Cell Proliferation and Alter the Mechanical Properties of Gingival and Cancer Cells
Suprewicz, Ł., Tokajuk, G., Cieśluk, M., Deptuła, P., Sierpińska, T., Wolak, P., Wollny, T., Tokajuk, J., Głuszek, S., Piktel, E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217914 · Cited by 19
Airway bacterial and fungal microbiome in chronic obstructive pulmonary disease
Liu, H., Liang, Z., Cao, N., Yi, X., Tan, X.-L., Liu, Z., Wang, F., Yang, Y., Li, C., Xiang, Z., et al. (2021) · Medicine in Microecology · doi:10.1016/j.medmic.2021.100035 · Cited by 19
Lung microbiome in healthy and diseased individuals
Evsyutina, Y., Komkova, I., Zolnikova, O., Tkachenko, P., & Ivashkin, V. T. (2017) · World Journal of Respirology · doi:10.5320/wjr.v7.i2.39 · Cited by 19
The lung microbiome: the perfect culprit for COPD exacerbations?
Gomez, C., & Chanez, P. (2016) · European Respiratory Journal · doi:10.1183/13993003.00270-2016 · Cited by 19
Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific
Taddei, L., Malvisi, L., Hui, D. S. C., Malvaux, L., Samoro, R. Z., Lee, S. H., Yeung, Y. C., Liu, Y., & Arora, A. K. (2022) · ERJ Open Research · doi:10.1183/23120541.00057-2022 · Cited by 18
Oropharyngeal Microbiota in Frail Older Patients Unaffected by Time in Hospital
Ewan, V. C., Reid, W. D. K., Shirley, M., Simpson, A. J., Rushton, S., & Wade, W. G. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00042 · Cited by 18
Nasopharyngeal Microbiota: Gatekeepers or Fortune Tellers of Susceptibility to Respiratory Tract Infections?
Huang, Y. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201707-1470ed · Cited by 17
Lower airway microbiota in COPD and healthy controls
Tangedal, S., Nielsen, R., Aanerud, M., Drengenes, C., Husebø, G. R., Lehmann, S., Knudsen, K. S., Hiemstra, P. S., & Eagan, T. (2024) · Thorax · doi:10.1136/thorax-2023-220455 · Cited by 19
Dissimilarity of Airway and Lung Tissue Microbiota in Smokers Undergoing Surgery for Lung Cancer
Reinhold, L., Möllering, A., Wallis, S., Palade, E., Schäfer, K., Drömann, D., Rupp, J., Graspeuntner, S., & Dalhoff, K. (2020) · Microorganisms · doi:10.3390/microorganisms8060794 · Cited by 17
Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease
Qi, Y.-J., Sun, X.-J., Wang, Z., Bin, Y.-F., Li, Y., Zhong, X., Bai, J., Deng, J., & He, Z. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000677 · Cited by 16
Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
Sivapalan, P., Rutishauser, J., Ulrik, C. S., Leuppi, J. D., Pedersen, L., Müeller, B., Eklöf, J. V., Biering‐Sørensen, T., Gottlieb, V., Armbruster, K., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01745-5 · Cited by 16
The association between the respiratory tract microbiome and clinical outcomes in patients with COPD
Yu, S., Zhang, H., Wan, L., Xue, M. F., Zhang, Y., & Gao, X. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127244 · Cited by 18
Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype
Pragman, A. A., Hodgson, S. W., Wu, T., Zank, A., Reilly, C. S., & Wendt, C. H. (2023) · ERJ Open Research · doi:10.1183/23120541.00595-2023 · Cited by 19
Short term dynamics of the sputum microbiome among COPD patients
Sinha, R., Weissenburger-Moser, L. A., Clarke, J., Smith, L. M., Heires, A. J., Romberger, D. J., & LeVan, T. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191499 · Cited by 17
Treatment of Acute Exacerbations in Chronic Obstructive Pulmonary Disease
Kunadharaju, R., & Sethi, S. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.06.008 · Cited by 16
Mapping bacterial diversity and metabolic functionality of the human respiratory tract microbiome
Mancabelli, L., Milani, C., Fontana, F., Lugli, G. A., Tarracchini, C., Turroni, F., van Sinderen, D., & Ventura, M. (2022) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2051336 · Cited by 14
Dynamics of the lung microbiome in intensive care patients with chronic obstructive pulmonary disease and community-acquired pneumonia
Huang, W., Wu, M., Huang, C.-C., Liu, S.-Y., Chen, H., Chen, Y.-Y., Hsu, J., & Huang, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-68100-4 · Cited by 15
Chronic Obstructive Pulmonary Disease Lung Microbiota Diversity May Be Mediated by Age or Inhaled Corticosteroid Use
Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C. H., & Isaacson, R. E. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.03320-14 · Cited by 15
GLUT3-mediated cigarette smoke-induced epithelial-mesenchymal transition in chronic obstructive pulmonary disease through the NF-kB/ZEB1 pathway
Ding, Y., Wang, Z., Zhang, Z., You, R., Yan, W. S., & Bian, T. (2024) · Respiratory Research · doi:10.1186/s12931-024-02785-3 · Cited by 14
Biomaterial therapeutic strategies for treatment of bacterial lung infections
Chee, E., & García, A. J. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100111 · Cited by 15
Plants from Arid and Semi-Arid Zones of Mexico Used to Treat Respiratory Diseases: A Review
Dávila-Rangel, I. E., Charles-Rodríguez, A. V., López-Romero, J. C., & Flores-López, M. L. (2024) · Plants · doi:10.3390/plants13060792 · Cited by 12
Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation
Cheng, Z.-X., & Zhang, J. (2024) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2023.0442 · Cited by 15
Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators
Gulati, S., & Wells, J. M. (2017) · Drugs · doi:10.1007/s40265-017-0713-5 · Cited by 12
Human airway and lung microbiome at the crossroad of health and disease (Review)
Raudoniūtė, J., Bironaitė, D., Bagdonas, E., Kulvinskienė, I., Jonaitytė, B., Danila, E., & Aldonytė, R. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11718 · Cited by 13
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis
Chakrabarti, A., Mar, J. S., Choy, D. F., Cao, Y., Rathore, N., Yang, X., Tew, G. W., Li, O., Woodruff, P. G., Brightling, C. E., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00836-2020 · Cited by 11
Combination of Cefditoren and N -acetyl- l -Cysteine Shows a Synergistic Effect against Multidrug-Resistant Streptococcus pneumoniae Biofilms
Llamosí, M., Sempere, J., Coronel, P., Gimeno, M., Yuste, J., & Domenech, M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03415-22 · Cited by 11
The contribution of respiratory microbiome analysis to a treatable traits model of care
Taylor, S., O’Farrell, H. E., Simpson, J. L., Yang, I. A., & Rogers, G. B. (2018) · Respirology · doi:10.1111/resp.13411 · Cited by 11
Emerging cellular and molecular interactions between the lung microbiota and lung diseases
Li, X., & Meng, X. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1992345 · Cited by 11
Gut–Lung Microbiota Interaction in COPD Patients: A Literature Review
Krūmiņa, A., Bogdanova, M., Gintere, S., & Vīksna, L. (2022) · Medicina · doi:10.3390/medicina58121760 · Cited by 12
Non-typeable Haemophilus influenzae isolates from patients with chronic obstructive pulmonary disease contain new phase-variable modA methyltransferase alleles controlling phasevarions
Atack, J. M., Murphy, T. F., Pettigrew, M. M., Seib, K. L., & Jennings, M. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-52429-6 · Cited by 11
Predicting Hyperoxia-Induced Lung Injury from Associated Intestinal and Lung Dysbiosis in Neonatal Mice
Chen, C., Chou, H., Yang, Y. S. H., Su, E. C., & Liu, Y. (2021) · Neonatology · doi:10.1159/000513553 · Cited by 11
Le microbiome pulmonaire en 2015
Andréjak, C., & Delhaès, L. (2015) · médecine/sciences · doi:10.1051/medsci/20153111011 · Cited by 12
Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy
Ezechukwu, H. C., Diya, C. A., Egoh, I. J., Abiodun, M. J., Grace, J.-U. A., Okoh, G. R., Adu, K. T., & Adegboye, O. A. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211032453 · Cited by 10
The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease
Abotsi, R. E., Nicol, M. P., McHugh, G., Simms, V. M., Rehman, A. M., Barthus, C., Ngwira, L. G., Kwambana-Adams, B., Heyderman, R. S., Odland, J. Ø., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00491-2021 · Cited by 10
Antibiotics for COPD exacerbations
Labaki, W. W., & Han, M. K. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30166-2 · Cited by 10

Authors: Huang, Y. J., Sethi, S., Murphy, T., Nariya, S., Boushey, H. A., & Lynch, S. V.
Affiliations: University of California, San Francisco (US)
Buffalo VA Medical Center (US)
University at Buffalo, State University of New York (US)
ORCID: Huang, Yvonne J.
Sethi, Sanjay
Murphy, Timothy
Boushey, Homer A.
Lynch, Susan V.
Venue: Journal of Clinical Microbiology
Publisher: American Society for Microbiology
Published: 2014-08
Volume: 52
Issue: 8
Pages: 2813-2823
ISSN: 0095-1137 (ISSN-L)
1098-660X
DOI: 10.1128/jcm.00035-14
PMC: PMC4136157
OpenAlex: W2135623379
Cited by: 323
References: 48
Citations by year: 2026: 11 · 2025: 12 · 2024: 25 · 2023: 25 · 2022: 30 · 2021: 33 · 2020: 35 · 2019: 28 · 2018: 24 · 2017: 38 · 2016: 27 · 2015: 29 · 2014: 6
FWCI: 26.69
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Journal of Clinical Microbiology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (K23HL105572, HL105572)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords: chronic obstructive pulmonary disease, COPD exacerbations, airway microbiome, sputum microbiota, Proteobacteria, antibiotic therapy, oral corticosteroids, inflammation
MeSH terms: Aged, Aged, 80 and over, DNA, Bacterial, DNA, Ribosomal, Humans, Longitudinal Studies, Male, Middle Aged, Phylogeny, Respiratory System, RNA, Ribosomal, 16S, Sputum, Cluster Analysis, Sequence Analysis, DNA, Proteobacteria, Pulmonary Disease, Chronic Obstructive, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Airway Microbiome Dynamics in Exacerbations of Chronic Obstructive Pulmonary Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks